Patient-Centered Weight Loss Program for Knee Replacement Patients (PACE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02728661 |
Recruitment Status :
Completed
First Posted : April 5, 2016
Last Update Posted : September 5, 2017
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
ARTHROPLASTY, REPLACEMENT | Behavioral: PACE Behavioral: Delayed PACE | Phase 1 Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 16 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Patient-Centered Weight Loss Program for Knee Replacement Patients |
Study Start Date : | May 2016 |
Actual Primary Completion Date : | June 2017 |
Actual Study Completion Date : | June 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: PACE
PACE participants will begin up to 6 weeks prior to their scheduled TKR and continue until 12 weeks after their TKR. Participants will be given personalized weight, dietary, and physical activity goals. Participants will be encouraged to monitor their dietary intake and physical activity using their preferred method of self-monitoring. Participants will have regular contact with their coaches either in-person or over the telephone on a weekly or bi-weekly basis, based on preference during the first 14 weeks (from up to 6 weeks pre-op to 12 weeks post-op). Further, participants may opt to receive regular text messages or emails from coaches if they prefer. At 12 weeks, PACE participants will enter a maintenance period and not have any contact with coaches.
|
Behavioral: PACE
PACE is an 14 week behavioral weight loss intervention developed specifically for knee replacement patients that starts up to 6 weeks prior to surgery. |
Experimental: Delayed PACE
After being notified of their randomized condition at baseline (up to 6 weeks prior to surgery), Delayed PACE participants will not have contact with coaches until 12 weeks after surgery. At 12 weeks after surgery, Delayed PACE participants will be given personalized weight, dietary, and physical activity goals. Participants will be encouraged to monitor their dietary intake and physical activity using their preferred method of self-monitoring. Participants will have regular contact with their coaches either in-person or over the telephone on a weekly or bi-weekly basis, based on preference during the first 14 weeks. Further, participants may opt to receive regular text messages or emails from coaches if they prefer.
|
Behavioral: Delayed PACE
Delayed PACE is an 14 week behavioral weight loss intervention developed specifically for knee replacement patients that starts 12 weeks after surgery. |
- Change in weight measured with a balance-beam scale [ Time Frame: Change from baseline to 12 and 26 weeks ]
- Change in physical function assessed by the timed up and go [ Time Frame: Change from baseline to 12 and 26 weeks ]
- Change in pain measured by WOMAC [ Time Frame: Change from baseline to 12 and 26 weeks ]
- Change in physical activity objectively-measured with accelerometry [ Time Frame: Change from baseline to 12 and 26 weeks ]
- Behavioral adherence assessed by session and self-monitoring completion [ Time Frame: 26 weeks post-op ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 79 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- BMI between 25-45 kg/m2
- Have a scheduled knee replacement at least 1 week away from baseline assessment
- Obtain physician approval to participate
- English speaking
- willing to attend 3 in-person assessments.
Exclusion Criteria:
- Have any contraindications to diet or weight loss
- Undergoing simultaneous bilateral knee replacement or have a scheduled or anticipated knee replacement for the contralateral knee in the next 26 weeks
- Have a mobility limiting comorbidity besides relating to TKR
- Taking anti-obesity medications
- Enrolled in a formal weight loss program
- Have had or is planning to have bariatric/gastric/lapband surgery
- Is planning to relocate out of the Chicago land area in the next 12 months.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02728661
United States, Illinois | |
Northwestern University | |
Chicago, Illinois, United States, 60611 |
Responsible Party: | Christine Pellegrini, Research Assistant Professor, Northwestern University |
ClinicalTrials.gov Identifier: | NCT02728661 |
Other Study ID Numbers: |
K12HS023011 ( U.S. AHRQ Grant/Contract ) |
First Posted: | April 5, 2016 Key Record Dates |
Last Update Posted: | September 5, 2017 |
Last Verified: | September 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Weight Loss Body Weight Changes Body Weight |